Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
7,594
-3,378
-31% -$1.2M 0.19% 82
2025
Q4
$3.59M Sell
10,972
-461
-4% -$146K 0.24% 64
2025
Q3
$3.23M Sell
11,433
-184
-2% -$53.4K 0.22% 72
2025
Q2
$3.24M Buy
11,617
+409
+4% +$116K 0.24% 62
2025
Q1
$3.49M Buy
11,208
+63
+0.6% +$18.6K 0.28% 59
2024
Q4
$2.9M Sell
11,145
-5,808
-34% -$1.72M 0.23% 68
2024
Q3
$5.46M Sell
16,953
-2,138
-11% -$699K 0.37% 52
2024
Q2
$5.97M Buy
19,091
+1,654
+9% +$486K 0.41% 52
2024
Q1
$4.97M Sell
17,437
-175
-1% -$51.2K 0.37% 56
2023
Q4
$5.07M Buy
17,612
+1,499
+9% +$408K 0.41% 51
2023
Q3
$4.33M Buy
16,113
+2,156
+15% +$538K 0.37% 58
2023
Q2
$3.12M Buy
13,957
+518
+4% +$120K 0.27% 77
2023
Q1
$3.24M Buy
13,439
+39
+0.3% +$9.57K 0.3% 70
2022
Q4
$3.54M Buy
13,400
+1,122
+9% +$301K 0.36% 58
2022
Q3
$2.75M Buy
12,278
+347
+3% +$84.1K 0.3% 69
2022
Q2
$2.88M Buy
11,931
+1,259
+12% +$309K 0.43% 45
2022
Q1
$2.56M Buy
10,672
+1,486
+16% +$341K 0.29% 78
2021
Q4
$2.04M Buy
9,186
+963
+12% +$203K 0.25% 92
2021
Q3
$1.74M Sell
8,223
-1,056
-11% -$243K 0.23% 97
2021
Q2
$2.25M Buy
9,279
+2,495
+37% +$614K 0.34% 74
2021
Q1
$1.66M Sell
6,784
-1,133
-14% -$270K 0.38% 72
2020
Q4
$1.82M Buy
7,917
+1,085
+16% +$250K 0.36% 77
2020
Q3
$1.75M Buy
6,832
+540
+9% +$134K 0.39% 70
2020
Q2
$1.48M Buy
6,292
+231
+4% +$52.7K 0.4% 67
2020
Q1
$1.23M Sell
6,061
-171
-3% -$37.4K 0.36% 76
2019
Q4
$1.5M Buy
6,232
+683
+12% +$151K 0.42% 71
2019
Q3
$1.07M Buy
5,549
+36
+0.7% +$6.91K 0.35% 83
2019
Q2
$1.02M Buy
5,513
+268
+5% +$48K 0.33% 81
2019
Q1
$991K Sell
5,245
-12
-0.2% -$2.29K 0.34% 85
2018
Q4
$1.02M Sell
5,257
-418
-7% -$81.5K 0.42% 76
2018
Q3
$1.18M Buy
5,675
+400
+8% +$78.8K 0.44% 67
2018
Q2
$971K Buy
5,275
+24
+0.5% +$4.25K 0.33% 85
2018
Q1
$900K Buy
5,251
+1,350
+35% +$248K 0.45% 67
2017
Q4
$679K Buy
3,901
+1,203
+45% +$213K 0.27% 94
2017
Q3
$503K Sell
2,698
-38
-1% -$6.73K 0.24% 92
2017
Q2
$473K Sell
2,736
-88
-3% -$14.3K 0.24% 100
2017
Q1
$464K Sell
2,824
-69
-2% -$11.5K 0.25% 94
2016
Q4
$422K Sell
2,893
-231
-7% -$34.8K 0.24% 97
2016
Q3
$526K Buy
3,124
+351
+13% +$59.4K 0.33% 91
2016
Q2
$422K Sell
2,773
-143
-5% -$22.2K 0.29% 95
2016
Q1
$437K Sell
2,916
-67
-2% -$9.95K 0.32% 87
2015
Q4
$484K Buy
+2,983
New +$469K 0.32% 88

Other funds holding AMGN

Asset Dedication LLC's AMGN Position: Q1 2026 in Review

Asset Dedication LLC reduced its Amgen (AMGN) stake by 31% in Q1 2026, selling an estimated $1.2M and leaving 7,594 shares worth $2.67M. The position accounts for 0.19% of the portfolio, ranked #82.

Asset Dedication LLC first reported a position in AMGN in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.97M in Q2 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Asset Dedication LLC held 7,594 shares of Amgen worth $2.67M as of Q1 2026.
  • Asset Dedication LLC sold 3,378 Amgen shares in Q1 2026, an estimated $1.2M.
  • Amgen made up 0.19% of Asset Dedication LLC's portfolio in Q1 2026, its #82 holding.
  • Asset Dedication LLC first reported a position in Amgen in Q4 2015 and has held it in 42 quarters since.
  • Asset Dedication LLC's Amgen position peaked at $5.97M in Q2 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Asset Dedication LLC's 13F filing for Q1 2026, filed 29 May 2026.